| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.567 | 0.012 | 0.739 | Lipoxygenase inhibitor | 0.491 0.02 CID_154699738 0.739 0.005 CID_154699894 | CID_154699894 | |
| 0.497 | 0.004 | 0.5 | 5-Lipoxygenase inhibitor | 0.25 0.016 CID_154699738 0.5 0.004 CID_154699894 | CID_154699894 | |
| 0.377 | 0.019 | 0.377 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.198 0.092 CID_154699738 0.305 0.038 CID_154699894 | ||
| 0.266 | 0.021 | 0.266 | 3C-like protease (Human coronavirus) inhibitor | 0.141 0.117 CID_154699738 0.169 0.075 CID_154699894 | ||
| 0.294 | 0.056 | 0.294 | Transcription factor STAT3 inhibitor | 0.186 0.154 CID_154699738 0.278 0.065 CID_154699894 | ||
| 0.244 | 0.008 | 0.244 | Rho-associated kinase II inhibitor | 0.096 0.034 CID_154699738 0.126 0.023 CID_154699894 | ||
| 0.225 | 0.004 | 0.225 | NMDA receptor agonist | 0.096 0.021 CID_154699738 0.165 0.006 CID_154699894 | ||
| 0.241 | 0.025 | 0.241 | Cytokine production inhibitor | 0.134 0.076 CID_154699738 0.142 0.069 CID_154699894 | ||
| 0.28 | 0.068 | 0.28 | Transcription factor STAT inhibitor | 0.257 0.082 CID_154699894 | ||
| 0.268 | 0.065 | 0.268 | 5 Hydroxytryptamine uptake stimulant | 0.236 0.096 CID_154699738 0.26 0.071 CID_154699894 | ||
| 0.297 | 0.094 | 0.316 | Calcium channel activator | 0.249 0.148 CID_154699738 0.316 0.077 CID_154699894 | CID_154699894 | |
| 0.206 | 0.004 | 0.206 | VCAM-1 antagonist | 0.053 0.008 CID_154699738 0.127 0.004 CID_154699894 | ||
| 0.206 | 0.004 | 0.206 | VCAM antagonist | 0.052 0.008 CID_154699738 0.128 0.004 CID_154699894 | ||
| 0.228 | 0.049 | 0.228 | LIM domain kinase 1 inhibitor | 0.156 0.092 CID_154699894 | ||
| 0.191 | 0.013 | 0.191 | Rho-associated kinase inhibitor | 0.093 0.038 CID_154699894 | ||
| 0.179 | 0.003 | 0.179 | NMDA receptor glycine site agonist | 0.096 0.019 CID_154699738 0.139 0.005 CID_154699894 | ||
| 0.199 | 0.03 | 0.206 | Cell wall synthesis inhibitor | 0.173 0.045 CID_154699738 0.206 0.028 CID_154699894 | CID_154699894 | |
| 0.163 | 0.013 | 0.163 | I kappa B kinase inhibitor | 0.095 0.043 CID_154699738 0.163 0.013 CID_154699894 | ||
| 0.233 | 0.086 | 0.29 | Tyrosine 3 hydroxylase inhibitor | 0.23 0.09 CID_154699738 0.29 0.038 CID_154699894 | CID_154699894 | |
| 0.148 | 0.005 | 0.148 | TRPM8 blocker | 0.052 0.015 CID_154699894 | ||
| 0.151 | 0.009 | 0.389 | Leukotriene synthesis inhibitor | 0.389 0.003 CID_154699738 0.166 0.007 CID_154699894 | CID_154699738 | |
| 0.173 | 0.032 | 0.181 | Adenylate cyclase stimulant | 0.132 0.098 CID_154699738 0.181 0.025 CID_154699894 | CID_154699894 | |
| 0.137 | 0.004 | 0.137 | Acetyl-CoA carboxylase inhibitor | 0.101 0.005 CID_154699738 0.099 0.005 CID_154699894 | ||
| 0.218 | 0.091 | 0.218 | Neuropeptide Y2 antagonist | 0.182 0.155 CID_154699738 0.203 0.115 CID_154699894 | ||
| 0.126 | 0.007 | 0.129 | I kappa B kinase 2 inhibitor | 0.08 0.023 CID_154699738 0.129 0.007 CID_154699894 | CID_154699894 | |
| 0.163 | 0.047 | 0.163 | Neuropeptide Y1 antagonist | 0.131 0.098 CID_154699738 0.153 0.061 CID_154699894 | ||
| 0.134 | 0.021 | 0.134 | CYP2A6 inhibitor | |||
| 0.118 | 0.013 | 0.118 | Histone deacetylase inhibitor | 0.068 0.043 CID_154699894 | ||
| 0.124 | 0.02 | 0.124 | Rho-associated kinase I inhibitor | |||
| 0.16 | 0.061 | 0.16 | Protein kinase (CK1) gamma 1 inhibitor | 0.111 0.109 CID_154699894 | ||
| 0.115 | 0.019 | 0.115 | Sphingosine 1-phosphate receptor 4 agonist | 0.076 0.04 CID_154699894 | ||
| 0.108 | 0.012 | 0.108 | Vanilloid 4 agonist | 0.076 0.048 CID_154699738 0.073 0.056 CID_154699894 | ||
| 0.099 | 0.004 | 0.099 | Acetyl-CoA carboxylase 2 inhibitor | 0.064 0.005 CID_154699738 0.064 0.005 CID_154699894 | ||
| 0.103 | 0.008 | 0.103 | Ca(v)3.2 blocker | 0.066 0.028 CID_154699738 0.079 0.015 CID_154699894 | ||
| 0.187 | 0.093 | 0.252 | Anticonvulsant | 0.252 0.057 CID_154699738 | CID_154699738 | |
| 0.095 | 0.004 | 0.095 | Acetyl-CoA carboxylase 1 inhibitor | 0.041 0.007 CID_154699738 0.036 0.007 CID_154699894 | ||
| 0.203 | 0.115 | 0.244 | Superoxide dismutase inhibitor | 0.186 0.134 CID_154699738 0.244 0.078 CID_154699894 | CID_154699894 | |
| 0.093 | 0.005 | 0.147 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.147 0.004 CID_154699894 | CID_154699894 | |
| 0.131 | 0.05 | 0.135 | Microtubule formation inhibitor | 0.117 0.064 CID_154699738 0.135 0.047 CID_154699894 | CID_154699894 | |
| 0.132 | 0.051 | 0.132 | DNA repair enzyme inhibitor | 0.128 0.059 CID_154699894 | ||
| 0.151 | 0.073 | 0.17 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.17 0.059 CID_154699894 | CID_154699894 | |
| 0.296 | 0.218 | 0.296 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.269 0.258 CID_154699738 | ||
| 0.133 | 0.055 | 0.151 | Papain-like protease (SARS coronavirus) inhibitor | 0.127 0.066 CID_154699738 0.151 0.033 CID_154699894 | CID_154699894 | |
| 0.086 | 0.01 | 0.101 | Growth hormone secretagogue receptor agonist | 0.101 0.007 CID_154699738 | CID_154699738 | |
| 0.154 | 0.079 | 0.154 | Polo-like kinase-3 inhibitor | 0.133 0.105 CID_154699894 | ||
| 0.145 | 0.071 | 0.169 | Sphingosine 1-phosphate receptor 5 antagonist | 0.169 0.035 CID_154699738 0.147 0.066 CID_154699894 | CID_154699738 | |
| 0.159 | 0.086 | 0.159 | ATPase inhibitor | 0.141 0.118 CID_154699894 | ||
| 0.084 | 0.012 | 0.084 | Sphingosine 1-phosphate receptor 5 agonist | 0.063 0.022 CID_154699894 | ||
| 0.149 | 0.078 | 0.361 | Peroxidase inhibitor | 0.143 0.082 CID_154699738 0.361 0.026 CID_154699894 | CID_154699894 | |
| 0.15 | 0.08 | 0.15 | Anticoagulant | 0.139 0.09 CID_154699894 | ||
| 0.115 | 0.048 | 0.115 | Adenylate kinase inhibitor | 0.109 0.055 CID_154699738 0.105 0.06 CID_154699894 | ||
| 0.075 | 0.008 | 0.075 | Immunoglobulin Fc receptor antagonist | 0.056 0.035 CID_154699738 0.063 0.018 CID_154699894 | ||
| 0.093 | 0.03 | 0.236 | Selectin antagonist | 0.236 0.009 CID_154699738 0.091 0.031 CID_154699894 | CID_154699738 | |
| 0.168 | 0.106 | 0.168 | Ca2+/calmodulin-dependent kinase II beta inhibitor | |||
| 0.137 | 0.077 | 0.137 | Protein kinase C nu inhibitor | |||
| 0.084 | 0.027 | 0.084 | Carbamoyl phosphate synthetase inhibitor | 0.083 0.027 CID_154699738 0.079 0.029 CID_154699894 | ||
| 0.227 | 0.17 | 0.227 | Toll-Like receptor 7 agonist | 0.206 0.194 CID_154699894 | ||
| 0.085 | 0.032 | 0.085 | I kappa B kinase 1 inhibitor | |||
| 0.072 | 0.019 | 0.089 | Factor IXa inhibitor | 0.089 0.013 CID_154699894 | CID_154699894 | |
| 0.131 | 0.079 | 0.131 | Histone deacetylase SIRT1 inhibitor | 0.118 0.093 CID_154699894 | ||
| 0.099 | 0.049 | 0.099 | Alpha 2d adrenoreceptor antagonist | |||
| 0.224 | 0.175 | 0.224 | Toll-Like receptor agonist | |||
| 0.064 | 0.016 | 0.064 | Secretase gamma inhibitor | 0.06 0.019 CID_154699738 | ||
| 0.077 | 0.03 | 0.077 | Exportin-1 inhibitor | 0.069 0.044 CID_154699738 | ||
| 0.166 | 0.119 | 0.166 | Histone acetyltransferase inhibitor | |||
| 0.106 | 0.061 | 0.106 | Aminopeptidase B inhibitor | 0.098 0.066 CID_154699738 0.106 0.061 CID_154699894 | ||
| 0.167 | 0.125 | 0.377 | Aldehyde oxidase inhibitor | 0.171 0.122 CID_154699738 0.377 0.05 CID_154699894 | CID_154699894 | |
| 0.049 | 0.007 | 0.049 | GHS receptor antagonist | 0.047 0.008 CID_154699738 0.033 0.02 CID_154699894 | ||
| 0.083 | 0.043 | 0.102 | GABA aminotransferase inhibitor | 0.102 0.026 CID_154699894 | CID_154699894 | |
| 0.055 | 0.015 | 0.055 | Factor XIa inhibitor | |||
| 0.073 | 0.034 | 0.073 | Glutamate (mGluR6) antagonist | 0.062 0.06 CID_154699738 0.064 0.053 CID_154699894 | ||
| 0.078 | 0.04 | 0.163 | CXC chemokine receptor antagonist | 0.163 0.009 CID_154699738 | CID_154699738 | |
| 0.106 | 0.069 | 0.124 | Mucolytic | 0.099 0.079 CID_154699738 0.124 0.051 CID_154699894 | CID_154699894 | |
| 0.134 | 0.101 | 0.134 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | |||
| 0.078 | 0.046 | 0.078 | Glutamate dehydrogenase inhibitor | 0.075 0.05 CID_154699738 0.077 0.048 CID_154699894 | ||
| 0.117 | 0.086 | 0.117 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.069 | 0.038 | 0.069 | Protease 3C (Human rhinovirus) inhibitor | 0.061 0.051 CID_154699738 | ||
| 0.05 | 0.02 | 0.05 | Factor VIIa inhibitor | 0.038 0.027 CID_154699738 0.034 0.031 CID_154699894 | ||
| 0.074 | 0.045 | 0.074 | Phospholipase D inhibitor | |||
| 0.048 | 0.021 | 0.048 | Neurokinin 2 agonist | |||
| 0.032 | 0.005 | 0.032 | Complement factor 1s inhibitor | 0.025 0.019 CID_154699738 0.026 0.015 CID_154699894 | ||
| 0.092 | 0.065 | 0.092 | Potassium channel (Voltage-sensitive) activator | |||
| 0.041 | 0.015 | 0.041 | Factor XI inhibitor | |||
| 0.084 | 0.06 | 0.09 | Vanilloid agonist | 0.09 0.047 CID_154699894 | CID_154699894 | |
| 0.062 | 0.041 | 0.062 | Transcription factor AP-1 inhibitor | |||
| 0.092 | 0.071 | 0.092 | Electrolyte absorption antagonist | 0.089 0.075 CID_154699738 | ||
| 0.026 | 0.008 | 0.026 | Factor IX inhibitor | 0.018 0.013 CID_154699894 | ||
| 0.04 | 0.021 | 0.04 | Glucose-6-phosphate dehydrogenase inhibitor | 0.035 0.032 CID_154699894 | ||
| 0.071 | 0.053 | 0.074 | Lipase inhibitor | 0.074 0.05 CID_154699894 | CID_154699894 | |
| 0.169 | 0.15 | 0.169 | Calpain inhibitor | |||
| 0.048 | 0.031 | 0.048 | Factor Xa inhibitor | |||
| 0.044 | 0.028 | 0.044 | GHS receptor agonist | 0.039 0.035 CID_154699738 | ||
| 0.166 | 0.15 | 0.166 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.03 | 0.014 | 0.03 | Calcium-sensing receptor agonist | 0.026 0.019 CID_154699738 | ||
| 0.143 | 0.128 | 0.143 | MAP kinase kinase 2 inhibitor | |||
| 0.057 | 0.044 | 0.057 | Carbonic anhydrase stimulant | 0.054 0.049 CID_154699738 0.056 0.045 CID_154699894 | ||
| 0.04 | 0.027 | 0.069 | Dopamine D5 agonist | 0.069 0.008 CID_154699894 | CID_154699894 | |
| 0.107 | 0.095 | 0.107 | Cathepsin H inhibitor | 0.104 0.1 CID_154699738 | ||
| 0.054 | 0.041 | 0.109 | Alcohol oxidase inhibitor | 0.109 0.016 CID_154699894 | CID_154699894 | |
| 0.185 | 0.173 | 0.185 | MAP kinase kinase 3 inhibitor | |||
| 0.027 | 0.017 | 0.027 | Histone deacetylase class IIb inhibitor | |||
| 0.027 | 0.017 | 0.027 | Histone deacetylase 6 inhibitor | |||
| 0.038 | 0.028 | 0.038 | Vascular adhesion protein 1 inhibitor | |||
| 0.033 | 0.025 | 0.033 | Purinergic P2X3 antagonist | |||
| 0.104 | 0.096 | 0.104 | Alpha-N-acetylglucosaminidase inhibitor | |||
| 0.048 | 0.041 | 0.048 | Ornithine carbamoyltransferase inhibitor | |||
| 0.026 | 0.019 | 0.026 | Cathepsin K inhibitor | |||
| 0.077 | 0.071 | 0.077 | Ornithine decarboxylase inhibitor | |||
| 0.07 | 0.064 | 0.087 | Keratolytic | 0.087 0.041 CID_154699894 | CID_154699894 | |
| 0.027 | 0.021 | 0.027 | Histone deacetylase class II inhibitor | |||
| 0.059 | 0.053 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.032 | 0.027 | 0.032 | Growth hormone secretagogue receptor antagonist | |||
| 0.02 | 0.018 | 0.02 | Glutamate (mGluR1a) agonist | |||
| 0.038 | 0.037 | 0.038 | Histamine H2 receptor agonist | |||
| 0.134 | 0.133 | 0.136 | Anesthetic general | 0.136 0.129 CID_154699894 | CID_154699894 | |
| 0.053 | 0.052 | 0.053 | Alpha 2 adrenoreceptor agonist | |||
| 0.064 | 0.063 | 0.095 | Glutamate decarboxylase inhibitor | 0.095 0.033 CID_154699894 | CID_154699894 | |
| 0.047 | 0.049 | 0.081 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.081 0.016 CID_154699894 | CID_154699894 | |
| 0.065 | 0.073 | 0.083 | Somatostatin 1 agonist | 0.083 0.048 CID_154699894 | CID_154699894 | |
| 0.129 | 0.137 | 0.345 | Interleukin antagonist | 0.345 0.039 CID_154699738 0.174 0.101 CID_154699894 | CID_154699738 | |
| 0.178 | 0.187 | 0.278 | Cholesterol antagonist | 0.278 0.106 CID_154699894 | CID_154699894 | |
| 0.009 | 0.022 | 0.015 | Human herpes virus 5 capsid protein P40 inhibitor | 0.015 0.006 CID_154699738 | CID_154699738 | |
| 0.131 | 0.145 | 0.18 | Antimitotic | 0.18 0.096 CID_154699894 | CID_154699894 | |
| 0.042 | 0.057 | 0.057 | CXC chemokine 1 receptor antagonist | 0.057 0.025 CID_154699894 | CID_154699894 | |
| 0.076 | 0.093 | 0.172 | Chemokine receptor antagonist | 0.172 0.024 CID_154699738 | CID_154699738 | |
| 0.022 | 0.038 | 0.031 | Growth hormone releasing factor agonist | 0.031 0.025 CID_154699738 | CID_154699738 | |
| 0.148 | 0.177 | 0.244 | DNA damaging | 0.244 0.084 CID_154699738 | CID_154699738 | |
| 0.128 | 0.166 | 0.145 | Neurotensin receptor agonist | 0.145 0.114 CID_154699894 | CID_154699894 | |
| 0.072 | 0.11 | 0.09 | Expectorant | 0.09 0.081 CID_154699894 | CID_154699894 | |
| 0.01 | 0.049 | 0.024 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.024 0.015 CID_154699894 | CID_154699894 | |
| 0.035 | 0.079 | 0.055 | Potassium channel (ATP-sensitive) activator | 0.055 0.022 CID_154699738 | CID_154699738 | |
| 0.036 | 0.082 | 0.058 | Potassium channel (Inward rectifier) activator | 0.058 0.023 CID_154699738 | CID_154699738 | |
| 0.101 | 0.153 | 0.131 | Sphingosine 1-phosphate receptor 2 antagonist | 0.131 0.073 CID_154699738 | CID_154699738 | |
| 0.071 | 0.134 | 0.101 | Carbonic anhydrase XV inhibitor | 0.101 0.066 CID_154699894 | CID_154699894 | |
| 0.085 | 0.15 | 0.116 | CDC-like kinase 1 inhibitor | 0.116 0.099 CID_154699894 | CID_154699894 | |
| 0.038 | 0.112 | 0.067 | Histidine decarboxylase inhibitor | 0.067 0.054 CID_154699894 | CID_154699894 | |
| 0.024 | 0.1 | 0.104 | CC chemokine 5 receptor antagonist | 0.104 0.007 CID_154699738 | CID_154699738 | |
| 0.141 | 0.22 | 0.188 | Peptidyltransferase inhibitor | 0.188 0.116 CID_154699738 0.187 0.118 CID_154699894 | CID_154699738 | |
| 0.048 | 0.131 | 0.059 | Beta 2 adrenoreceptor agonist | 0.059 0.052 CID_154699894 | CID_154699894 | |
| 0.015 | 0.102 | 0.036 | Estradiol 17 beta-dehydrogenase inhibitor | 0.036 0.035 CID_154699894 | CID_154699894 | |
| 0.114 | 0.206 | 0.137 | Phospholipase C inhibitor | 0.137 0.136 CID_154699894 | CID_154699894 | |
| 0.062 | 0.166 | 0.105 | Alkylator | 0.105 0.083 CID_154699738 | CID_154699738 | |
| 0.107 | 0.224 | 0.395 | Tumour necrosis factor alpha release inhibitor | 0.395 0.028 CID_154699738 | CID_154699738 | |
| 0.044 | 0.178 | 0.08 | Potassium channel activator | 0.08 0.075 CID_154699738 | CID_154699738 | |
| 0.031 | 0.169 | 0.104 | CC chemokine receptor antagonist | 0.104 0.033 CID_154699738 | CID_154699738 | |
| 0.061 | 0.211 | 0.095 | DOPA decarboxylase inhibitor | 0.095 0.088 CID_154699894 | CID_154699894 | |
| 0.071 | 0.227 | 0.145 | Diuretic | 0.145 0.081 CID_154699738 | CID_154699738 | |
| 0.043 | 0.201 | 0.087 | Creatine kinase inhibitor | 0.087 0.077 CID_154699894 | CID_154699894 | |
| 0.073 | 0.254 | 0.158 | Dyrk kinase inhibitor | 0.158 0.129 CID_154699894 | CID_154699894 | |
| 0.078 | 0.266 | 0.131 | Interleukin 6 antagonist | 0.131 0.123 CID_154699738 | CID_154699738 | |
| 0.064 | 0.257 | 0.159 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.159 0.123 CID_154699894 | CID_154699894 | |
| 0.05 | 0.285 | 0.271 | Interleukin 1 antagonist | 0.271 0.015 CID_154699738 | CID_154699738 | |
| 0.003 | 0.289 | 0.04 | Estrogen receptor alpha agonist | 0.04 0.021 CID_154699894 | CID_154699894 | |
| 0.054 | 0.4 | 0.132 | NOS3 expression enhancer | 0.132 0.094 CID_154699894 | CID_154699894 | |
| 0.004 | 0.459 | 0.047 | Estrogen agonist | 0.047 0.037 CID_154699894 | CID_154699894 | |
| 0.018 | 0.492 | 0.136 | Estrogen receptor beta antagonist | 0.136 0.02 CID_154699894 | CID_154699894 | |
| 0.022 | 0.558 | 0.146 | Estrogen antagonist | 0.146 0.025 CID_154699894 | CID_154699894 | |
| 0.02 | 0.702 | 0.212 | Interleukin 1b antagonist | 0.212 0.017 CID_154699738 | CID_154699738 | |
| 0.026 | 0.878 | 0.209 | Sodium/bile acid cotransporter inhibitor | 0.209 0.176 CID_154699894 | CID_154699894 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |